Histamine-2 Receptor Antagonist [EPC]

287507 reported adverse events

Drugs of this class: FAMOTIDINE CIMETIDINE FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE IBUPROFEN AND FAMOTIDINE FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE NIZATIDINE RANITIDINE FAMOTIDINE 10 MG FAMOTIDINE TABLET, FILM-COATED FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE TABLET, CHEWABLE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET

These side effects are most commonly reported by patients taking drugs of the Histamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 BREAST CANCER 25001
1 PROSTATE CANCER 22378
2 COLORECTAL CANCER 17702
3 BLADDER CANCER 16845
4 RENAL CANCER 16388
5 INCORRECT DOSE ADMINISTERED 10351
6 CHRONIC KIDNEY DISEASE 10049
7 NAUSEA 10008
8 OESOPHAGEAL CARCINOMA 9695
9 FATIGUE 9100
See all common reactions for Histamine-2 Receptor Antagonist [EPC]

Drugs of the Histamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLORECTAL CANCER 17702 0.3745
1 RENAL CANCER 16388 0.3519
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 350 0.3462
3 SMALL INTESTINE CARCINOMA 716 0.3424
4 OESOPHAGEAL CARCINOMA 9695 0.3334
5 HEPATIC CANCER 7617 0.3331
6 GASTRIC CANCER 7662 0.3151
7 BLADDER CANCER 16845 0.2931
8 PROSTATE CANCER 22378 0.2918
9 NEPHROGENIC ANAEMIA 1274 0.2889
See all enriched reactions for Histamine-2 Receptor Antagonist [EPC]